X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

[Video] Compliance into the Weeds: Episode 130- Corrosive Subcultures

Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...

Read More >

SEC Amends Financial Statement Requirements for Business Acquisitions and Dispositions

In May 2020, the US Securities and Exchange Commission announced amendments to the rule and forms re...

Read More >

Purdue Pharma, Pills, and Pot: The Need for Insurers to Have a Plan

Every day in the United States, 130 people die from opioid overdoses. To date, the opioid epidemic, ...

Read More >

Does a Preference for Hiring Veterans Create a Disparate Impact Based on Gender?

In a recent claim filed against one of our clients, an aggrieved employee alleged that a manager who...

Read More >

[Audio] Nota Bene Episode 87: What Buyers and Sellers Need to Know About Distressed Financial Transactions with Ariel Yehezkel

What is in store for companies that are on the cusp of financial distress and might be facing potent...

Read More >

[Audio] The 2 a.m. Idea

Today we share our conversation with Haley Altman, founder and CEO of Doxly, which was recently acqu...

Read More >